Growth Metrics

Oric Pharmaceuticals (ORIC) Other Working Capital Changes (2019 - 2026)

Oric Pharmaceuticals filings provide 8 years of Other Working Capital Changes readings, the most recent being $679000.0 for Q1 2026.

  • Quarterly Other Working Capital Changes rose 18.09% to $679000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.7 million through Mar 2026, up 14.87% year-over-year, with the annual reading at -$1.8 million for FY2025, 1149.65% down from the prior year.
  • Other Working Capital Changes hit $679000.0 in Q1 2026 for Oric Pharmaceuticals, up from -$2.1 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $2.4 million in Q1 2024 and bottomed at -$2.1 million in Q4 2025.
  • Average Other Working Capital Changes over 5 years is -$229470.6, with a median of $211000.0 recorded in 2023.
  • The largest annual shift saw Other Working Capital Changes crashed 867.42% in 2022 before it surged 318.4% in 2024.
  • Oric Pharmaceuticals' Other Working Capital Changes stood at -$1.3 million in 2022, then grew by 21.3% to -$1.0 million in 2023, then tumbled by 34.73% to -$1.4 million in 2024, then crashed by 55.98% to -$2.1 million in 2025, then skyrocketed by 132.15% to $679000.0 in 2026.
  • Per Business Quant, the three most recent readings for ORIC's Other Working Capital Changes are $679000.0 (Q1 2026), -$2.1 million (Q4 2025), and -$782000.0 (Q3 2025).